Aldeyra Therapeutics Inc. (ALDX) Stock Price

7.70 ▼ -0.05 (-0.65%)
Open: 7.80 Vol: 56.28K Day's range: 7.45 - 7.80 Aug 13, 16:00 EDT
IEX Real-Time Price
Free Stock Screener
Loading chart ...
ALDX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY NEUTRAL
  5 mins 30 mins Hourly Daily Weekly
MA5 7.68▲ 7.68▲ 7.69▲ 7.42▲ 7.52▲
MA10 7.69▲ 7.70▼ 7.68▲ 7.23▲ 7.97▼
MA20 7.66▲ 7.46▲ 7.38▲ 7.43▲ 7.95▼
MA50 7.31▲ 7.24▲ 7.26▲ 7.99▼ 7.43▲
MA100 7.36▲ 7.52▲ 7.66▲ 7.89▼ 6.30▲
MA200 7.76▼ 7.93▼ 8.05▼ 7.46▲ 6.72▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.017▼ 0.012▲ 0.032▲ 0.083▲ -0.154▼
RSI 63.843▲ 64.393▲ 63.520▲ 52.919▲ 49.632▼
STOCH 35.556     54.258     75.422     59.220     28.862    
WILL %R -60.000     -23.077▲ -10.345▲ -16.667▲ -62.745    
CCI 3.794     26.608     47.257     132.665▲ -75.496    
Latest Filters Detected On ALDX
▲ BREAK $ALDX Price Breaks 10 Days High Set Alert
MA $ALDX Price Crossed Above MA(26) Set Alert
▼ MA $ALDX MA(20) Crossed Below MA(200) Set Alert
RSI $ALDX RSI(14) Crossed Above 50 Set Alert
▲ RSI&VOL $ALDX RSI Cross Up and Volume Set Alert
Aldeyra Therapeutics Inc. News
Aldeyra Therapeutics, Inc. (ALDX) CEO Todd Brady on Q2 2018 Results - Earnings Call Transcript
Thursday, August 09, 2018 02:50 PM
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Q2 2018 Earnings Conference Call August 9, 2018 8:00 AM ET Executives Joshua Reed - CFO Todd Brady - CEO, President & Director Analysts Neil Carnahan - Stifel, ...
Aldeyra Therapeutics Announces Second Quarter 2018 Financial Results and Provides Corporate Update
Thursday, August 09, 2018 01:41 PM
LEXINGTON, Mass., Aug. 9, 2018 /PRNewswire/ -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the lives of ...
Aldeyra Therapeutics Schedules Webcast and Conference Call to Provide Second Quarter 2018 Financial Results and Corporate Update
Wednesday, August 01, 2018 05:00 PM
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with immune-mediated diseases, will hol...
ALDX historical stock data
date open high low close volume
13/08/18 7.80 7.80 7.45 7.70 56,279
10/08/18 7.55 7.89 7.45 7.75 85,382
09/08/18 7.20 7.5527 7.05 7.45 71,418
08/08/18 7.04 7.30 6.95 7.15 65,618
07/08/18 7.00 7.10 6.85 7.05 66,022
06/08/18 6.95 7.10 6.75 6.95 48,280
03/08/18 7.20 7.30 6.90 6.95 58,937
02/08/18 7.10 7.45 7.05 7.20 50,122
01/08/18 6.95 7.20 6.95 7.15 76,774
31/07/18 7.00 7.15 6.8256 6.95 77,180
Quote Details
Bid:7.65
Ask:7.70
52wk Low:3.90
52wk High:11.90
Vol:56.28K
Avg Vol(3m):2M
1Y Chng:+81.18%
1M Chng:-4.35%
Add to Watch List
More Information
Index NASDAQ Composite
Market Cap. 161.51M